Stock Research: Clariane

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Clariane

PAR:CLARI FR0010386334
12
  • Value
    4
  • Growth
    65
  • Safety
    Safety
    57
  • Combined
    24
  • Sentiment
    3
  • 360° View
    360° View
    12
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Clariane SE operates healthcare and medical facilities, including residential centers for the elderly, follow-up and rehabilitation centers, hospitalization at home, and home nursing services. The company's establishments are located in France, Italy, Belgium, and Germany. In the last fiscal year, the company had 61798 employees, a market cap of $2104 million, profits of $5014 million, and revenue of $5468 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 12 (better than 12% compared with alternatives), overall professional sentiment and financial characteristics for the stock Clariane are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Clariane. The consolidated Value Rank has an attractive rank of 57, which means that the share price of Clariane is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 57% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 65, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 3. Professional investors are more confident in 97% other stocks. Worryingly, the company has risky financing, with a Safety rank of 4. This means 96% of comparable companies have a safer financing structure than Clariane. ...read more

more
Index
CAC All
SBF 120
Dividends Europe
Diversity Europe
Human Rights
Sound Pay Europe
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out
Learn More

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
57 48 100 97
Growth
65 96 1 47
Safety
Safety
4 1 6 4
Sentiment
3 6 8 67
360° View
360° View
12 19 10 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
25 1 15 73
Opinions Change
38 50 69 50
Pro Holdings
n/a 49 14 70
Market Pulse
1 3 5 16
Sentiment
3 6 8 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
57 48 100 97
Growth
65 96 1 47
Safety Safety
4 1 6 4
Combined
24 44 18 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
44 15 95 79
Price vs. Earnings (P/E)
91 95 100 81
Price vs. Book (P/B)
100 100 97 100
Dividend Yield
1 1 100 100
Value
57 48 100 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
20 82 41 63
Profit Growth
98 88 6 84
Capital Growth
9 42 6 11
Stock Returns
100 100 7 31
Growth
65 96 1 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
12 10 14 10
Refinancing
1 1 1 5
Liquidity
10 17 24 16
Safety Safety
4 1 6 4

Similar Stocks

Discover high‑ranked alternatives to Clariane and broaden your portfolio horizons.

Rubis

ENXTPA:RUI
Country: France
Industry: Gas Utilities
Size: Medium
Full Stock Analysis

Societe Generale

ENXTPA:GLE
Country: France
Industry: Diversified Banks
Size: Medium
Full Stock Analysis

Savencia

ENXTPA:SAVE
Country: France
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.